FDA Law Weekly

Acambis plc - Vaccine maker expands manufacturing capability with acquisition

Agency for Healthcare Research and Quality - Report outlines planning guidelines for care during mass casualty events

American Pharmaceutical Partners, Inc. - U.S. FDA grants approval for Adenosine

American Red Cross - Integrated health campaign saves African children from malaria and measles

Amylin Pharmaceuticals, Inc. - U.S. FDA grants approval of Byetta (exenatide) injection for diabetes

Applied Imaging Corp. - U.S. FDA grants clearance to market breast cancer assessment test

Benitec, Ltd. - Biotech firm announces clinical candidate for hepatitis C therapy

Berlex, Inc. - Further trial data awaited for Bonefos in the U.S.

BioPort Corp. - HHS awards BioShield contract for AVA anthrax vaccine

Biovail Corporation - Approval letter received from U.S. FDA for Tramadol ODT

Case Western Reserve University - Alefacept for treatment of psoriasis reviewed

Ciphergen Biosystems, Inc. - ProteinChip System developer reports financial results for first-quarter 2005

Columbia University, New York - Pathogen effector protein screening used, Legionella factors identified

Depomed, Inc. - FDA approves extended-release ciprofloxacin hydrochloride for SUI treatment

Dynavax Technologies Corp. - Flu vaccine shows potential against pandemic flu in preclinical model

A.P. Pharma, Inc. - Pharmaceutical firm reports loss of $0.05 per share, clinical trial update

AMS Health Sciences, Inc. - Sales increase in April for nutritional supplements company

Adherex Technologies, Inc. - Phase II trial of Adh-1 to examine eight tumor types that express N-cadherin

Adiana, Inc. - Treatment phase of EASE transcervical sterilization trial completed

Agilent Technologies, Inc. - Genomics technology launched in India

Albany College of Pharmacy - The new integrin antagonist TA138 thwarts angiogenic growth

Ambit Biosciences - Biopharmaceutical company raises $31M in series C financing

AstraZeneca - Data: Cerovive demonstrates a reduction in disability in stroke patients

Auckland City Hospital - Patients with inflammation may have greater benefit from statin therapy

Bandim Health Project - New research in the area of tuberculosis vaccines detailed

Barrier Therapeutics, Inc. - Pharmaceutical firm launches U.S. sales organization

Beijing Institute of Radiation Medicine - Researchers detail new studies and findings in the area of diagnostics

Berkeley Natl. Lab - Possible Alzheimer "switch" identified

Brigham & Women's Hospital, Boston - Long-term treatment for C. pneumoniae did not reduce the rate of CV events

CNRS, Orleans - Adhesion properties of endothelial cell ARM-1 characterized

Capital University of Medical Sciences, Beijing - Findings describe new data in neuroscience research

Cardima, Inc. - Medical device maker reports 13% decrease in sales

Catholic University of Louvain - Dermal pharmacokinetics of fluconazole determined by microdialysis

Cellerant Therapeutics, Inc. - Company raises $16M to advance stem cell-based therapies

Cephalon, Inc. - CEP-1347 clinical trial in Parkinson disease discontinued

Children's Hosp. of the King's Daughters, Norfolk - CroFab appears to be a safe and efficacious antivenom for children and adults

Chiron Corp. - Four grants will aid new approaches in medical research and health policy